Author:
Faissner Simon,Mishra Manoj,Kaushik Deepak K.,Wang Jianxiong,Fan Yan,Silva Claudia,Rauw Gail,Metz Luanne,Koch Marcus,Yong V. Wee
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference54 articles.
1. Ransohoff, R. M., Hafler, D. A. & Lucchinetti, C. F. Multiple sclerosis—a quiet revolution. Nat. Rev. Neurol. 11, 134–142 (2015).
2. Lublin, F. et al. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet 387, 1075–1084 (2016).
3. Montalban, X. et al. Ocrelizumab vs. placebo in primary progressive multiple sclerosis. New Engl. J. Med. 376, 209–220 (2017).
4. Kappos L. et al. Efficacy and safety of siponimod in secondary progressive multiple sclerosis—results of the placebo controlled, double-blind, Phase III EXPAND study. ECTRIMS Online Library (2016).
5. Lassmann, H., van Horssen, J. & Mahad, D. Progressive multiple sclerosis: pathology and pathogenesis. Nat. Rev. Neurol. 8, 647–656 (2012).
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献